Notably, we prioritized 10 target genes, CACNA1C, CLU, CSNK2B, GABBR1, GRIN2A, MAPK3, NOTCH4, SRR, TNF, and SYNGAP1, which were differentially expressed between schizophrenia cases and controls, validated in mouse models and MalaCards directly (Fig. 4c, Table 1, Supplementary Table S9). The gene discussed is SYNGAP1; the disease is schizophrenia.